Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 15 Apr 2016
At a glance
- Drugs Darifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 27 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 27 Jul 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 14 Dec 2009 New trial record